Past Event - 5 March 2009
CNETS organised a free seminar, its very first public event, which was held in Singapore
at the National Cancer Centre Theatre on 5 March 2009.
"Targeted Radiotherapy for Neuroendocrine Tumors"
Presented by Professor Dr. Richard P. Baum
Chairman and Director,
Dept. of Nuclear Medicine / Center for PET/CT
Zentralklinik Bad Berka, Germany
One of the first successful applications of radiopharmaceuticals for treatment of solid tumors
is the use of radiolabeled somatostatin analogs to target metastatic neuroendocrine cancers.
The majority of these tumors possess somatostatin receptors and therefore they can be visualised
and targeted with the radiolabeled peptide. This peptide receptor radiotherapy (PRRT) usually
provides excellent clinical benefits with minimal side effects.
Dr. Baum is among the world's experts in targeted radiotherapy for neuroendocrine tumors, and
his clinic treats over 1,000 patients per year using this new approach. His talk covers the
needs of neuroendocrine patients, interdisciplinary collaboration, targeted radiotherapy, how
therapy is personalised, and how the molecular response to treatment is measured.
The talk was introduced by Dr. Joseph Wee, Senior Consultant, Department of Radiation Oncology
and Head of Clinical Trials & Epidemiological Studies at the National Cancer Centre of Singapore.
Venue: National Cancer Centre of Singapore (NCCS), 11 Hospital Drive, Level 4 Theatre,
Singapore, 169610, Tel: +65-6436-8000
Location Map: Google Map
Date: Thursday 5 March 2009
Time: 12.00noon - 2.00pm (a light buffet lunch was served)
Audience: Physicians, medical students, patients & caregivers
Registration is now closed. If you missed the event, please review the recording
(refer to column at right).